Cargando…

Targeting breast cancer stem cells directly to treat refractory breast cancer

For patients with refractory breast cancer (BC), integrative immunotherapies are emerging as a critical component of treatment. However, many patients remain unresponsive to treatment or relapse after a period. Different cells and mediators in the tumor microenvironment (TME) play important roles in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Liping, Han, Juan, Lin, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213424/ https://www.ncbi.nlm.nih.gov/pubmed/37251931 http://dx.doi.org/10.3389/fonc.2023.981247

Ejemplares similares

Editorial: Cancer stem cells as attractive targets for breast cancer therapy
por: Ibrahim, Sherif Abdelaziz, et al.
Publicado: (2023)

Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy?
por: Ruiu, Roberto, et al.
Publicado: (2022)

Fate decisions of breast cancer stem cells in cancer progression
por: Xu, Hui, et al.
Publicado: (2022)

Hyaluronidase and pH Dual-Responsive Nanoparticles for Targeted Breast Cancer Stem Cells
por: Li, Weinan, et al.
Publicado: (2021)

Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance
por: Sridharan, Sangita, et al.
Publicado: (2019)

Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells
por: Yousefnia, Saghar, et al.
Publicado: (2020)

Stem Cell Therapy and Breast Cancer Treatment: Review of Stem Cell Research and Potential Therapeutic Impact Against Cardiotoxicities Due to Breast Cancer Treatment
por: Sharp, Thomas E., et al.
Publicado: (2014)

Repositioning Aspirin to Treat Lung and Breast Cancers and Overcome Acquired Resistance to Targeted Therapy
por: Li, Ling, et al.
Publicado: (2020)

Editorial: The Role of Breast Cancer Stem Cells in Clinical Outcomes
por: Raman, Dayanidhi, et al.
Publicado: (2020)

The Prostaglandin E2 Pathway and Breast Cancer Stem Cells: Evidence of Increased Signaling and Potential Targeting
por: Walker, Olivia L., et al.
Publicado: (2022)

Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness
por: Sridharan, Sangita, et al.
Publicado: (2019)

Targeted Therapy for Breast Cancer Prevention
por: den Hollander, Petra, et al.
Publicado: (2013)

Effective Targeting of Raf-1 and Its Associated Autophagy by Novel Extracted Peptide for Treating Breast Cancer Cells
por: El-Fadl, Hebatullah M. Abou, et al.
Publicado: (2021)

New Strategies to Direct Therapeutic Targeting of PML to Treat Cancers
por: Wolyniec, Kamil, et al.
Publicado: (2013)

Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer
por: Hoyos, Valentina, et al.
Publicado: (2022)

The CXCL8-CXCR1/2 Axis as a Therapeutic Target in Breast Cancer Stem-Like Cells
por: Ruffini, Pier Adelchi
Publicado: (2019)

Construction and Identification of New Molecular Markers of Triple-Negative Breast Cancer Stem Cells
por: Liu, Tingting, et al.
Publicado: (2021)

Molecular Immunotherapy: Promising Approach to Treat Metastatic Colorectal Cancer by Targeting Resistant Cancer Cells or Cancer Stem Cells
por: Forster, Stefan, et al.
Publicado: (2020)

MicroRNA-1246 Mediates Drug Resistance and Metastasis in Breast Cancer by Targeting NFE2L3
por: Dai, Yue-chu, et al.
Publicado: (2021)

Matrix metalloproteinases as therapeutic targets in breast cancer
por: Kwon, Mi Jeong
Publicado: (2023)

OCT4 and SOX2 Specific Cytotoxic T Cells Exhibit Not Only Good Efficiency but Also Synergize PD-1 Inhibitor (Nivolumab) in Treating Breast Cancer Stem-Like Cells and Drug-Resistant Breast Cancer Mice
por: Peng, Wei, et al.
Publicado: (2022)

NEDD4 Plays Roles in the Maintenance of Breast Cancer Stem Cell Characteristics
por: Jeon, Seon-Ae, et al.
Publicado: (2020)

Stereotactic partial breast irradiation in primary breast cancer: A comprehensive review of the current status and future directions
por: Takanen, Silvia, et al.
Publicado: (2022)

Identification of Immune-Related Therapeutically Relevant Biomarkers in Breast Cancer and Breast Cancer Stem Cells by Transcriptome-Wide Analysis: A Clinical Prospective Study
por: Wang, Linbang, et al.
Publicado: (2021)

Targeting Metabolic Deregulation Landscapes in Breast Cancer Subtypes
por: Serrano-Carbajal, Erandi A., et al.
Publicado: (2020)

Targeted Therapeutic Strategies for Triple-Negative Breast Cancer
por: Li, Ying, et al.
Publicado: (2021)

Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy
por: Deng, Xiyun, et al.
Publicado: (2022)

BCMA (TNFRSF17) Induces APRIL and BAFF Mediated Breast Cancer Cell Stemness
por: Pelekanou, Vasiliki, et al.
Publicado: (2018)

Stem Cells and Cellular Origins of Breast Cancer: Updates in the Rationale, Controversies, and Therapeutic Implications
por: Zhou, Jiaojiao, et al.
Publicado: (2019)

VLDLR disturbs quiescence of breast cancer stem cells in a ligand-independent function
por: Yang, Mengying, et al.
Publicado: (2022)

Heterogeneity and Plasticity of Human Breast Cancer Cells in Response to Molecularly-Targeted Drugs
por: Bousoik, Emira, et al.
Publicado: (2019)

Enrichment of CD44 in Exosomes From Breast Cancer Cells Treated With Doxorubicin Promotes Chemoresistance
por: Wang, Xiaohong, et al.
Publicado: (2020)

Cardiac Toxicity From Adjuvant Targeting Treatment for Breast Cancer Post-Surgery
por: Fu, Zhenkun, et al.
Publicado: (2022)

Therapeutic Targeting of Cancer Stem Cells
por: Maugeri-Saccà, Marcello, et al.
Publicado: (2011)

Metabolic Targeting of Cancer Stem Cells
por: Mukha, Anna, et al.
Publicado: (2020)

Association of Body Mass Index With Somatic Mutations in Breast Cancer
por: Chen, Bo, et al.
Publicado: (2021)

Early Breast Cancers During Pregnancy Treated With Breast-Conserving Surgery in the First Trimester of Gestation: A Feasibility Study
por: Blundo, Concetta, et al.
Publicado: (2021)

Skp2 is a Promising Therapeutic Target in Breast Cancer
por: Wang, Zhiwei, et al.
Publicado: (2012)

Novel Pathways for Targeting Tumor Angiogenesis in Metastatic Breast Cancer
por: Harry, Jordan A., et al.
Publicado: (2021)

Conducive target range of breast cancer: Hypoxic tumor microenvironment
por: Cheng, Wen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8tf6u0s5q7mnuppp9go27p1q9l